Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy

Lancet Oncol. 2006 Aug;7(8):693-4. doi: 10.1016/S1470-2045(06)70797-5.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Female
  • Humans
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, Non-Hodgkin / drug therapy*
  • Prednisone / administration & dosage
  • Pregnancy
  • Pregnancy Complications, Neoplastic / drug therapy*
  • Rituximab
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Vincristine
  • Doxorubicin
  • Cyclophosphamide
  • Prednisone

Supplementary concepts

  • CHOP protocol